PFE
Pfizer Inc
28.70$
+0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +51.6% | -79.2% | -263.4% | – | +0.1% | -65.3% | -124.9% | – | +16.2% | -51.1% | -68.1% | – | |
| – | +7.1% | +4.0% | -0.3% | +1.4% | +2.1% | -9.7% | +0.4% | +2.3% | +1.5% | -4.4% | +0.6% | – | |
| – | -19.9% | +81.8% | -6.4% | +33.0% | -35.4% | -4.0% | +19.4% | -1.0% | +11.9% | +20.9% | -8.5% | – | |
| – | – | -139.5% | – | – | +232.9% | -165.6% | – | -101.9% | – | -208.9% | – | – | |
| – | +28.9% | -32.6% | -9.5% | +2.2% | +40.9% | -38.5% | +9.6% | -2.6% | +40.4% | -48.4% | +22.2% | – | |
| – | -1,338.3% | – | +165.6% | -144.7% | -21.1% | – | +20.7% | -161.5% | +152.9% | – | +168.3% | – | |
| – | +0.0% | +2.5% | +0.3% | +0.0% | +0.0% | +2.4% | +0.3% | 0.0% | +0.0% | +0.0% | +0.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +20.9% | -10.5% | -70.0% | – | +51,316.7% | -104.1% | +833.9% | – | |
| – | – | -190.6% | -50.1% | +88.5% | +10.3% | +2.2% | -38.9% | -22.5% | – | -579.2% | +28.3% | – | |
| – | -155.1% | – | – | -88.3% | -212.5% | – | -43.0% | -240.8% | – | – | -229.0% | – | |
| – | +58.6% | -90.8% | -726.4% | – | -4.3% | -69.5% | -167.8% | – | +12.6% | -51.6% | -86.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.